Blog
RSS FeedPosted by Michael Wonder on 23 Apr 2020
COVID-19: Critical Care Advisory Group
23 April 2020 - In April 2020, PHARMAC convened a group of clinical experts from across New Zealand for an ...
Posted by Michael Wonder on 23 Apr 2020
Recent PHARMAC funding decisions
22 April 2020 - You may have read about PHARMAC’S decision this week to scrap a lung cancer drug funding ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 28 Aug 2019
Patient Voice Aotearoa calls for PHARMAC reform
28 August 2019 - Patient Voice Aotearoa has launched a petition calling for the Minister of Health to initiate an ...
Posted by Michael Wonder on 18 Aug 2019
Lack of transparency hampers cancer drug debate
19 August 2019 - The current debate raging over cancer drug funding is emotional, and the different agenda of lobby ...
Posted by Michael Wonder on 07 Aug 2019
DHB backs PHARMAC in making ‘hard calls’
7 August 2019 - Hauora Tairawhiti has a role of supporting drugs-funding agency PHARMAC in its ‘‘hard calls” but not ...
Posted by Michael Wonder on 01 Jul 2019
UK’s drug-buying agency CEO: Why we like to say ‘yes’
1 July 2019 - While more than 100 medicines sit on Pharmac's waiting list, some for 10 years, the UK's own ...
Posted by Michael Wonder on 28 May 2019
Feilding woman nervous about PHARMAC's decision to change epilepsy medication brands
28 My 2019 - Judy Lawrence recalls vividly the day she suffered a seizure walking down the stairs eight years ...
Posted by Michael Wonder on 28 May 2019
PHARMAC head defends drug agency's funding
28 May 2019 - PHARMAC is under intense pressure from clinicians, health advocacy groups and patients to fund more medicines ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 14 May 2019
PHARMAC publishes list of applications to be considered by PTAC later this month
14 May 2019 - The list includes a number of medicines for patients with breast cancer. ...
Posted by Michael Wonder on 01 May 2019
PHARMAC sheds a little more light on procedures in savvy political move
1 May 2019 - Steve Maharey has just secured special status on David Clark's Christmas card list. ...
Posted by Michael Wonder on 29 Apr 2019
Proposal to decline inactive applications
29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...
Posted by Michael Wonder on 29 Apr 2019
PHARMAC proposes to give more clarity about funding decisions
29 April 2019 - An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and ...
Posted by Michael Wonder on 08 Apr 2019
Greater flexibility needed by PHARMAC to fund new medicines, including cancer drug - expert
8 April 2019 - The fight continues in New Zealand for funding of a life-prolonging drug that targets advanced breast ...